A recent study reveals that patients who discontinue blockbuster slimming jabs like Mounjaro or Wegovy may regain reduced body mass much more quickly than those who halt conventional diet and exercise plans.
Published data in a prominent health publication demonstrates that while overweight people can lose substantial amounts of their total mass while using the jabs, the weight returns at an average rate of 0.8 kg per month after stopping.
"People purchasing such medications need to be informed of the risk of quick weight regain when the treatment ends," cautioned researcher Dr. Susan Jebb.
Such speed of regain means a reversion to pre-treatment mass within about one and a half years.
Analyzing Treatments
The research, which examined 37 of trials involving thousands of patients, contrasted the effects of the injectable medications with other pills.
Scientists emphasize that individuals who lose weight through lifestyle changes alone typically see a less rapid creep back—approximately 0.1 kg a month—after stopping.
Understanding the Rapid Regain
Nutrition scientists propose the way of the jabs explains the amplified rebound.
GLP-1 drugs imitate a natural hormone called glucagon-like peptide-1, which moderates appetite.
"Long-term administration of GLP-1 levels several times higher than the body's typical production may cause the body to generate a reduced amount of its own natural GLP-1, and could lessen responsiveness to its actions," noted Dr. Adam Collins, a dietetics specialist.
"Withdrawal of this hormone supplement means appetite is no longer kept in check, making binge eating much more probable."
An Ongoing Issue?
Medical guidelines recommend the jabs for people with weight-linked health risks, alongside recommended diet and exercise modifications.
A number of clinicians argue that, given the likelihood of weight regain, the treatment should be considered ongoing.
This perspective is echoed by drug manufacturers, who say that the results "emphasize the chronic nature of excess weight," comparing it to managing diseases like diabetes.
Patient Experiences
Users who have stopped the jabs report a powerful return of cravings.
"It felt as if something flipping and you're instantly extremely hungry," recalled a patient.
This challenge is compounded if individuals have not developed permanent dietary or behavioural modifications during treatment.
Widespread Adoption
Survey data indicate that a significant number of people in the UK have tried weight-loss jabs in the last 12 months, with demand remaining high.
- Use is more common among females compared to men.
- The 40s and 50s age group shows the highest usage rates.
- Many obtain the medications through private prescriptions rather than the NHS.
In conclusion, researchers stress that while the jabs are potent tools for shedding pounds, they are not a magic solution and lasting health benefits hinges on combined behavioural support.
